These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26898032)

  • 1. The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia.
    Stefanović V; Mihajlović G; Nenadović M; Dejanović SD; Borovcanin M; Trajković G
    Vojnosanit Pregl; 2015 Dec; 72(12):1085-92. PubMed ID: 26898032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
    Steiner J; Frodl T; Schiltz K; Dobrowolny H; Jacobs R; Fernandes BS; Guest PC; Meyer-Lotz G; Borucki K; Bahn S; Bogerts B; Falkai P; Bernstein HG
    Schizophr Bull; 2020 Feb; 46(2):363-373. PubMed ID: 31504969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
    Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
    Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Kelly CW; McEvoy JP; Miller BJ
    Schizophr Res; 2019 Jul; 209():193-197. PubMed ID: 31118157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of C-reactive protein in response-guided therapy of pyogenic liver abscess.
    Law ST; Li KK
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):179-86. PubMed ID: 24025976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study.
    Liemburg EJ; Nolte IM; ; Klein HC; Knegtering H
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():89-94. PubMed ID: 29778547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Mori N; McEvoy JP; Miller BJ
    Schizophr Res; 2015 Dec; 169(1-3):30-35. PubMed ID: 26475215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
    Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
    Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of drug prescribing in inpatients with first episode of schizophrenia spectrum disorder: The role of guidelines
.
    Stašević M; Stašević Karličić I; Grgurević A; Divac N
    Int J Clin Pharmacol Ther; 2020 Jul; 58(7):387-394. PubMed ID: 32352369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic Expression After Shoulder Surgery: Normalization Curve of Serum Inflammatory Markers.
    Rhee SM; Kim MS; Kim JD; Ro K; Ko YW; Rhee YG
    Arthroscopy; 2021 Jan; 37(1):71-82. PubMed ID: 32971139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives.
    Carrizo E; Fernández V; Quintero J; Connell L; Rodríguez Z; Mosquera M; Acosta A; Baptista T
    Schizophr Res; 2008 Aug; 103(1-3):83-93. PubMed ID: 18436434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of inflammation-associated factors in children with Mycoplasma pneomoniaepneumonia and concomitant systemic inflammatory response syndrome].
    Han XH; Liu LY; Jing H; Liu TY; Zhao YQ; Shang YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):347-50. PubMed ID: 17706037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
    Volavka J; Czobor P; Derks EM; Bitter I; Libiger J; Kahn RS; Fleischhacker WW;
    J Clin Psychiatry; 2011 Jul; 72(7):955-61. PubMed ID: 21824456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.